Wall Street Associates’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$616K Hold
20,000
0.41% 90
2016
Q3
$604K Hold
20,000
0.21% 114
2016
Q2
$547K Hold
20,000
0.22% 115
2016
Q1
$536K Hold
20,000
0.22% 121
2015
Q4
$566K Hold
20,000
0.16% 196
2015
Q3
$557K Sell
20,000
-436,800
-96% -$15.8M 0.11% 213
2015
Q2
$18.9M Sell
456,800
-240,800
-35% -$8.82M 1.78% 4
2015
Q1
$21.2M Sell
697,600
-12,500
-2% -$324K 2% 2
2014
Q4
$14.1M Buy
710,100
+15,000
+2% +$335K 1.35% 7
2014
Q3
$13.8M Sell
695,100
-39,800
-5% -$838K 1.43% 7
2014
Q2
$16.7M Buy
734,900
+3,900
+0.5% +$69.4K 1.44% 6
2014
Q1
$9.4M Sell
731,000
-10,000
-1% -$143K 0.77% 36
2013
Q4
$10.1M Buy
741,000
+408,800
+123% +$4.88M 0.83% 27
2013
Q3
$3.68M Buy
+332,200
New +$3.31M 0.34% 107

Other funds holding RGEN

Wall Street Associates's RGEN Position: Q4 2016 in Review

Wall Street Associates held its Repligen (RGEN) position steady in Q4 2016 at 20,000 shares worth $616K. The position accounts for 0.41% of the portfolio, ranked #90.

Wall Street Associates first reported a position in RGEN in Q3 2013 and has held it in 14 quarters since. The position peaked at $21.2M in Q1 2015. 184 funds tracked by Wall St. Rank hold RGEN as of Q4 2016.

  • Wall Street Associates held 20,000 shares of Repligen worth $616K as of Q4 2016.
  • Wall Street Associates left its Repligen share count unchanged in Q4 2016.
  • Repligen made up 0.41% of Wall Street Associates's portfolio in Q4 2016, its #90 holding.
  • Wall Street Associates first reported a position in Repligen in Q3 2013 and has held it in 14 quarters since.
  • Wall Street Associates's Repligen position peaked at $21.2M in Q1 2015.
  • 184 funds tracked by Wall St. Rank held Repligen as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.